![Sathi Sathiyaseelan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sathi Sathiyaseelan
Compliance Officer bij
AKSTON BIOSCIENCES CORPORATION
Profiel
Thillainayagam Sathiyaseelan is currently Vice President-Quality & Compliance at Akston Biosciences Corp.
since 2025.
Formerly, worked as Director-Bioanalytical Development at SmartCells, Inc. Education includes a doctorate from the University of Massachusetts.
Actieve functies van Sathi Sathiyaseelan
| Bedrijven | Functie | Begin |
|---|---|---|
| AKSTON BIOSCIENCES CORPORATION | Compliance Officer | 01-10-2025 |
Eerdere bekende functies van Sathi Sathiyaseelan
| Bedrijven | Functie | Einde |
|---|---|---|
SmartCells, Inc.
 SmartCells, Inc. Medical SpecialtiesHealth Technology Develops breakthrough treatment for diabetes called SmartInsulin | Corporate Officer/Principal | - |
Opleiding van Sathi Sathiyaseelan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
SmartCells, Inc.
SmartCells, Inc. Medical SpecialtiesHealth Technology Develops breakthrough treatment for diabetes called SmartInsulin | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akston Biosciences Corp.
 Akston Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for cats, dogs and animals | Health Technology |
